Rare diseases
Investigational molecules
Locations
239 conditions with trials, the busiest first
357 trials across Europe, recruiting first
Study of Durvalumab and Tremelimumab for Patients with Advanced Liver Cancer
FranceStudy on Rifaximin for Delaying Hepatic Encephalopathy in Cirrhosis Patients
BelgiumStudy on the Safety of LSTA1 with Standard Care for Patients with Advanced Head and Neck Cancer or Cholangiocarcinoma
SpainStudy on Fluorescence-Guided Surgery for Colorectal Liver Metastases Using SGM-101 and Indocyanine Green for Patients with Colorectal Cancer
The NetherlandsStudy on Efinopegdutide and Semaglutide for Adults with Non-Alcoholic Steatohepatitis (NASH) Before Cirrhosis
AustriaStudy on Long-term Safety of Linerixibat for Treating Itchy Skin in Patients with Primary Biliary Cholangitis
BelgiumStudy on the Effects of Semaglutide on Insulin Resistance and Lipid Metabolism in Women with Obesity and Non-Alcoholic Fatty Liver Disease
DenmarkStudy on Atezolizumab and Bevacizumab for Patients with Unresectable Liver Cancer
GermanyStudy on Maralixibat Chloride for Treating Itchy Skin in Patients with Cholestatic Pruritus
FranceStudy on Norucholic Acid for Treating Primary Sclerosing Cholangitis in Patients
AustriaStudy of Dasatinib and Quercetin combination for treating liver fibrosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
The NetherlandsStudy of lenvatinib treatment benefits in patients with non-resectable liver cancer (hepatocellular carcinoma) who are on liver transplant waiting list after unsuccessful TACE therapy
FranceThe therapies tested most often in Hepatobiliary disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
